Abstract
Stereotactic biopsies are frequently performed to secure definitive diagnosis for brain tumor patients. Fundamentally, there are two major difficulties in these endeavors. First, because of intra-tumoral heterogeneity inherent in many forms of brain cancer, biopsies taken from one region may yield a different diagnosis than if another area is biopsied. Second, stereotactic needle biopsies inherently rely on mathematical algorithms for targeting, without real-time visualization of the actual biopsy site. This article describes the novel MRI-based technologies that can potentially afford neurosurgeons the opportunity to address these challenges.
Original language | English (US) |
---|---|
Pages (from-to) | 1-5 |
Number of pages | 5 |
Journal | Expert Review of Medical Devices |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2014 |
Bibliographical note
Publisher Copyright:© 2015 Informa UK, Ltd.
Keywords
- MRI-guided surgery
- brain tumor
- glioblastoma multiforme
- restriction spectrum imaging
- stereotactic biopsy